President Barack Obama's fiscal 2013 budget proposal goes against his goals of advancing biomedical innovation, creating jobs and curbing medical costs for seniors, said John Castellani, president and CEO of the Pharmaceutical Research and Manufacturers of America. Castellani criticized proposed mandatory Medicare Part D rebates, patent-settlement restrictions and shorter data exclusivity for biologic drugs.

Related Summaries